C Cordón-Cardó

1.0k total citations
19 papers, 891 citations indexed

About

C Cordón-Cardó is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C Cordón-Cardó has authored 19 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C Cordón-Cardó's work include Bladder and Urothelial Cancer Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). C Cordón-Cardó is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). C Cordón-Cardó collaborates with scholars based in United States, Germany and Spain. C Cordón-Cardó's co-authors include Robert A. Good, Ehud Razin, Joseph C. Presti, William R. Fair, James R. Howe, Xiaofeng Zhang, Philip O. Livingston, Govindaswami Ragupathi, Ming-Lan Lu and Feng‐Xia Liang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and British Journal of Cancer.

In The Last Decade

C Cordón-Cardó

19 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Cordón-Cardó United States 13 419 274 246 203 139 19 891
SC Peiper United States 12 480 1.1× 163 0.6× 122 0.5× 451 2.2× 203 1.5× 22 1.1k
S A Cannistra United States 15 405 1.0× 368 1.3× 78 0.3× 324 1.6× 96 0.7× 24 1.1k
Satoshi Amada Japan 21 402 1.0× 239 0.9× 161 0.7× 276 1.4× 124 0.9× 38 1.5k
B E Elliott Canada 17 571 1.4× 382 1.4× 101 0.4× 351 1.7× 71 0.5× 29 1.2k
A. Miyajima Japan 14 348 0.8× 452 1.6× 193 0.8× 223 1.1× 32 0.2× 27 992
C. Henne Germany 10 737 1.8× 551 2.0× 76 0.3× 310 1.5× 89 0.6× 15 1.2k
Bernard Klein France 17 645 1.5× 370 1.4× 67 0.3× 462 2.3× 127 0.9× 32 1.4k
Bruce G. Kulander United States 12 220 0.5× 130 0.5× 128 0.5× 238 1.2× 207 1.5× 13 833
Fumitaka Numa Japan 17 361 0.9× 101 0.4× 114 0.5× 165 0.8× 56 0.4× 42 800
Erica N Evans United States 19 487 1.2× 379 1.4× 68 0.3× 187 0.9× 191 1.4× 44 1.2k

Countries citing papers authored by C Cordón-Cardó

Since Specialization
Citations

This map shows the geographic impact of C Cordón-Cardó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Cordón-Cardó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Cordón-Cardó more than expected).

Fields of papers citing papers by C Cordón-Cardó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Cordón-Cardó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Cordón-Cardó. The network helps show where C Cordón-Cardó may publish in the future.

Co-authorship network of co-authors of C Cordón-Cardó

This figure shows the co-authorship network connecting the top 25 collaborators of C Cordón-Cardó. A scholar is included among the top collaborators of C Cordón-Cardó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Cordón-Cardó. C Cordón-Cardó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cordón-Cardó, C, et al.. (2024). Editorial Expression of Concern: Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. British Journal of Cancer. 131(12). 1946–1946. 1 indexed citations
2.
Dalbagni, Guido, et al.. (2001). Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.. PubMed. 7(9). 2797–801. 26 indexed citations
3.
Brinck, Ulrich, et al.. (2000). Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas.. PubMed. 19(6B). 5211–6. 3 indexed citations
4.
Brinck, Ulrich, et al.. (1998). Prognostic relevance of histologic grading, the cell cycle-associated antigen Ki-S1 and cell cycle regulators in malignant fibrous histiocytomas: a multivariate analysis.. PubMed. 82. 232–8. 2 indexed citations
5.
Wu, Renlong, Iman Osman, Xue‐Ru Wu, et al.. (1998). Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.. PubMed. 58(6). 1291–7. 78 indexed citations
6.
Pasche, Boris, Yan Luo, Pulivarthi H. Rao, et al.. (1998). Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.. PubMed. 58(13). 2727–32. 77 indexed citations
7.
Zhang, Xiaofeng, et al.. (1998). Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.. PubMed. 4(11). 2669–76. 66 indexed citations
8.
Howe, James R., et al.. (1997). DNA extraction from paraffin-embedded tissues using a salting-out procedure: a reliable method for PCR amplification of archival material.. PubMed. 12(3). 595–601. 86 indexed citations
9.
Presti, Joseph C., et al.. (1996). Expression of the retinoblastoma gene product in renal tumors.. PubMed. 16(2). 549–56. 13 indexed citations
10.
Drudis, Teresa, et al.. (1994). The pathology of low-grade adenosquamous carcinoma of the breast. An immunohistochemical study.. PubMed. 29 ( Pt 2). 181–97. 21 indexed citations
11.
Cordón-Cardó, C, et al.. (1993). Biological markers of prognosis in transitional cell carcinoma of the bladder: current concepts.. PubMed. 11(3). 137–44. 16 indexed citations
12.
Cordón-Cardó, C, et al.. (1991). On the origins of clinical drug resistance.. PubMed. 2(4). 227–33. 9 indexed citations
13.
Presti, Joseph C., et al.. (1991). Molecular genetic alterations in superficial and locally advanced human bladder cancer.. PubMed. 51(19). 5405–9. 200 indexed citations
14.
Jaffe, E A, Douglas Armellino, Gordon K. Lam, et al.. (1989). IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells.. The Journal of Immunology. 143(12). 3961–3966. 39 indexed citations
15.
Cordón-Cardó, C, et al.. (1988). Immunopathology--new help for the clinician.. PubMed. 6(1). 31–45. 1 indexed citations
16.
Tolkoff-Rubin, Nina, W. Hansen, C Cordón-Cardó, et al.. (1987). Diagnosis of Renal Proximal Tubular Injury by Urinary Immunoassay for a Proximal Tubular Antigen, the Adenosine Deaminase Binding Protein. Nephrology Dialysis Transplantation. 2(3). 143–148. 16 indexed citations
17.
Pumarola, Tomàs & C Cordón-Cardó. (1986). [The AIDS virus].. Medicina Clínica. 86(3). 115–7. 9 indexed citations
18.
Razin, Ehud, C Cordón-Cardó, & Robert A. Good. (1981). Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes.. Proceedings of the National Academy of Sciences. 78(4). 2559–2561. 200 indexed citations
19.
Razin, Ehud, Arleen B. Rifkind, C Cordón-Cardó, & Robert A. Good. (1981). Selective growth of a population of human basophil cells in vitro.. Proceedings of the National Academy of Sciences. 78(9). 5793–5796. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by SC Peiper Breakdown of academic impact, for papers by S A Cannistra Breakdown of academic impact, for papers by Satoshi Amada Breakdown of academic impact, for papers by B E Elliott Breakdown of academic impact, for papers by A. Miyajima Breakdown of academic impact, for papers by C. Henne Breakdown of academic impact, for papers by Bernard Klein Breakdown of academic impact, for papers by Bruce G. Kulander Breakdown of academic impact, for papers by Fumitaka Numa Breakdown of academic impact, for papers by Erica N Evans
Rankless by CCL
2026